Found 28 matching trials
Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma PHASE2 In patients with cholangiocarcinoma therapeutic effects have been reported ...
Show More Location
Technical University of Munich at the Klinikum rechts der Isar II. Medizinische Klinik Ismaninger Str. 22
Learn More & Join Trial
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment PHASE3 The purpose of this study is to look at the efficacy and safety of Irinotec...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer PHASE1 The purpose of this study is to learn about the safety and potential benefi...
Show More Location
Northwestern University
Learn More & Join Trial
Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer PHASE2 RATIONALE: Sorafenib tosylate may stop the growth of tumor cells by blockin...
Show More Location
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle
Learn More & Join Trial
Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas PHASE1 The purpose of this research study is to find the maximum tolerated dose of...
Show More Location
University of Chicago
Learn More & Join Trial
Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer PHASE2 This is a randomized phase 2 trial of gemcitabine + carboplatin + nivolumab...
Show More Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) PHASE1 The purpose of this trial is to measure the safety and effectiveness of epc...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone rituximab and lenalidomide rituximab and bendamustine rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin gemcitabine and oxaliplatin Epcoritamab rituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisone Lenalidomide rituximab, ifosfamide, carboplatin, and etoposide phosphate Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Rituximab and Lenalidomide Epcoritamab Learn More & Join Trial
KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) PHASE2 The purpose of this study is to estimate the overall response rate of subje...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma PHASE1 This study will be separated into 3 distinct phases designated as the Phase...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets PHASE2 The purpose of this study is to evaluate the safety and impact on survival ...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial